🚑🏥New study suggests benefit of EVT compared to medical management does not vary by interhospital-transfer status 🧠Study in acute anterior-circulation large vessel occlusion patients with large infarcts Read more here!👇 journals.sagepub.com/doi/abs/10.117…

🧵In a meta-analysis of randomized controlled trials that enrolled patients with acute ischemic stroke beyond 4.5 hours of time last known well, administration of thrombolysis (compared with placebo) led to a higher odds of a good functional outcome despite a higher odds of sICH.

Many thanks Johanna Seiden, MD MPH for highlighting our paper with UCL Stroke Research, Lucas Boersma and Moniek Maarse in JAMA Neurology! Promising preliminary findings to be tested in a RCT - ELAPSE will test the hyposthesis that LAAO+DOAC is superior to DOAC alone. Stroke Research Center Bern Schweizerischer Nationalfonds (SNF)

🧵#STROKE April Highlights are here: 🌟Cognitive decline became evident 10–13 years poststroke, emphasizing the long-term nature of stroke-related neurocognitive changes and vascular risk management poststroke. Mitchell Elkind @profhayward Sarah Pendlebury Hugo J. Aparicio, MD, MPH, FAHA Sudha Seshadri, MD

Get With The Guidelines #Stroke Registry analysis shows that minimally invasive surgery was associated with lower in-hospital mortality. These findings support efforts to understand the durable impact of this intervention among ICH patients. #AHAJournals ahajournals.org/doi/full/10.11…

Pesach Sameach, Happy Passover A Seder wouldn’t be a seder if it didn’t last at least 4 hours. But here’s the pesach story in 2 mins courtesy of Robin Williams 💙

LAAO and stroke: We summarize current evidence & ongoing trials: promising option for AF patients to avoid OAC (i.e. after ICH, CAA) or if DOAC alone is not enough (i.e. after #breakthroughstroke) Alexander Benz ⁦ELAPSE⁩ ⁦Stroke AHA/ASA⁩ ahajournals.org/doi/10.1161/ST…

Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study - The Lancet Neurology thelancet.com/journals/laneu…

Tonight I light a candle and think of my relatives who perished in the Holocaust. And I think of my Dad, who was born into it and was forever shaped by it. Z”L. #YomHashoah

Survivors of ischemic #stroke face a high risk of early heart complications (within 4 weeks): 👉11.1% develop #ACS 👉8.8% #Afib 🚨Early monitoring is critical! Read more🖇️ tinyurl.com/429kd6w6 #StrokeHeartSyndrome #ESCstroke Jacopo Imberti Liverpool Centre for Cardiovascular Science

Less than half of countries worldwide provide comprehensive acute stroke care, with only 30% of patients globally having access to mechanical thrombectomy. This disparity underscores the need for equitable access to life-saving interventions. Learn more & donate to help increase

So lucky within the TV ISDN to have access to an excellent 24/7 thrombectomy service OUH. Privileged to work alongside the stroke team Royal Berkshire NHS Foundation Trust facilitating ever decreasing door in door out times. Let’s make this standard of care accessible to all! #WorldThrombectomyDay

Presented at #ESOC2025: Among 550 patients with stroke due to large-vessel occlusion who had presented within 4.5 hours after onset, 90-day functional outcomes were better with intravenous tenecteplase before thrombectomy than with thrombectomy alone. Read the full BRIDGE-TNK

Presented at #ESOC2025: Tirofiban, an IV antiplatelet, given as an adjunct to IVT, improved the odds of excellent functional outcome in patients with AIS, at the cost of an increased risk of intracranial bleeding in the ASSET-IT trial #VoiceOfStroke

#ESOC2025 🏃🏻‍♀️ESCAPE MEVO sub analysis 👉🏻 prognosis by image 🧠 👉🏻EVT <12 hs not > good functional outcome 👉🏻 Good collateral status > benefit 👉🏻 ⏱️<180 min > benefit

Professor David Werring on safely thrombolysis in stroke patients with microbleeds and/or superficial siderosis 🧠💉 #ESOC2025 #VoiceofStroke #Stroke #StrokeResearch European Stroke Org #Helsinki #Finland

🚨 Reshaping stroke care in Africa: The PINGS-II trial in Ghana shows a simple phone-based nurse-led program can boost blood pressure control from 43% to 67%! Scalable, affordable, and impactful. #Stroke #GlobalHealth #ESOC2025

🧠🚑MAP-STROKE 🗺️ 👉🏻prehospital triage: AHA vs multivariable tool 👉🏻> benefit LVO 👉🏻> benefit rural

Stratified by on-treatment CRP level in the CONVINCE trial, those with CRP level <2mg/L on colchicine had ~40% reduced risk of recurrent MACE. Lower is better: in a secondary analysis, patients who achieved a CRP level <2mg/L on colchicine treatment had a reduced risk of MACE.

New study from the ANGEL-ASPECT trial unveils a 6-item scale predicting futile recanalization in large vessel occlusion stroke patients undergoing EVT. This tool could revolutionize clinical decision-making and patient outcomes! 🌟🧠 #StrokeResearch #MedicalInnovation JNIS